All dollar figures are Canadian dollars and all images are from Cronos, including its investor presentation, unless otherwise noted.
Summary
Cronos (CRON) is a large Canadian cannabis company. After a $2.4 billion investment from Altria (MO), Cronos is the third-most valuable cannabis company by market cap and the fourth-most valuable by enterprise value. Along with its great balance sheet, the company also boasts an intriguing U$100 million partnership with Ginkgo Bioworks, which could potentially develop technology to synthesize individual cannabinoids directly and economically. If successful, that deal may allow Cronos